Autism Spectrum Disorder Trial, Recruiting NCT06472115 Sponsor: Stanford University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06472115
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 6 years and 10 years 11 months old at the time of signing up for the study
  • Children who have been diagnosed with Autism Spectrum Disorder (ASD), confirmed through their medical history and records, including assessments done by a psychologist
  • Children with an IQ score of 75 or higher, based on their history and available medical records
  • Families where the child and at least one parent show three or more examples of the family adjusting their routines or behaviours to accommodate the child's strong need for things to stay the same (based on screening questionnaires)
  • Families where both the parent and child are English-speaking and are able to take part in study activities on a consistent basis

Who may not be able to join:

  • Children who have significant difficulties with hearing, language, or physical movement
  • Children whose behavioural or medication-based treatments for anxiety or rigid, sameness-seeking behaviours have not been stable for at least two months before the study starts, or where changes to those treatments are expected during the trial
  • Parents or caregivers who have previously completed formal training in a programme called SPACE (Supportive Parenting for Anxious Childhood Emotions)
  • Children who are currently receiving psychological therapy or counselling specifically for anxiety or strong needs for sameness
  • Children who have a notable history of refusing to attend school, harming themselves, or having thoughts of suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer Phillips, PhD, Stanford University

Phone: (650) 724-6026

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 January 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline in parent rated Dimensional Assessment of Restricted Behavior (DARB) Scores during treatment.; Change from baseline in clinician rated clinical global impressions scale scores during treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov